Is Carbo recalled?
243 FDA recalls mention Carbo. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Carbo.
Class I · High risk Ongoing Oct 31, 2023
Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class I · High risk Ongoing Oct 31, 2023
Reason Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Class I · High risk Ongoing Oct 18, 2023
Reason Presence of Particulate Matter: Silicone
Class I · High risk Terminated Oct 2, 2023
Reason Presence of Particulate Matter: identified as glass.
Class II · Moderate risk Terminated Aug 17, 2023
Reason Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Class II · Moderate risk Terminated Jul 14, 2023
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated Jul 14, 2023
Reason Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk Terminated Jul 7, 2023
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II · Moderate risk Terminated Apr 28, 2023
Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II · Moderate risk Ongoing Jan 30, 2023
Reason CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the…
Class I · High risk Ongoing Jan 30, 2023
Reason Non-Sterility: FDA analysis found unopened products to have bacterial contamination.
Class II · Moderate risk Ongoing Jan 30, 2023
Reason CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the…
Class I · High risk Ongoing Jan 30, 2023
Reason Non-Sterility: FDA analysis found unopened products to have bacterial contamination.
Class II · Moderate risk Completed Dec 2, 2022
Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Class II · Moderate risk Completed Dec 2, 2022
Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Class II · Moderate risk Completed Dec 2, 2022
Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Class II · Moderate risk Completed Dec 2, 2022
Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Class II · Moderate risk Completed Dec 2, 2022
Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Class II · Moderate risk Completed Dec 2, 2022
Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Class II · Moderate risk Completed Dec 2, 2022
Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Class I · High risk Terminated Nov 28, 2022
Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Class I · High risk Terminated Nov 28, 2022
Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Class I · High risk Terminated Oct 4, 2022
Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration
Class I · High risk Terminated Oct 4, 2022
Reason Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration